3,253 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 587 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,253
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$517M
2 +$511M
3 +$381M
4
JP Morgan Chase
JP Morgan Chase
New York
+$314M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$271M
Name Holding Trade Value Shares
Change
Change in
Stake
2426
$611K
2427
$611K
2428
$611K
2429
$610K
2430
$610K
2431
$606K
2432
$605K
2433
$605K
2434
$605K
2435
$604K
2436
$604K
2437
$602K
2438
$601K
2439
$600K
2440
$600K
2441
$600K
2442
$599K
2443
$599K
2444
$598K
2445
$597K
2446
$595K
2447
$592K
2448
$591K
2449
$591K
2450
$591K